Related Experiment Video

Updated: Apr 24, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

9.9K

[Matrix metalloproteinases and hypertrophic cardiomyopathy]

E V Privalova, V Iu Kaplunova, M V Kozhevnikova

    Kardiologiia
    |September 2, 2014
    PubMed

    Insights

    Matrix metalloproteinases (MMPs) influence hypertrophic cardiomyopathy (HCMP) progression. Specific MMP-3 gene variants and altered MMP/TIMP-1 levels correlate with disease severity and cardiac remodeling in HCMP patients.

    Area of Science:

    • Cardiovascular Biology
    • Genetics
    • Biochemistry

    Context:

    • Hypertrophic cardiomyopathy (HCMP) prognosis is linked to clinical presentation.
    • Matrix metalloproteinases (MMPs) are implicated in cardiac fibroformation and remodeling.
    • Gene polymorphisms regulating MMPs may affect HCMP clinical course.

    Purpose:

    • To investigate the impact of MMPs and their polymorphisms on HCMP progression.
    • To analyze the association between MMP-3 gene polymorphism (rs3025058) and clinical variants in HCMP.
    • To evaluate markers of fibroformation (MMP-3, TIMP-1, TIMP-2, collagen IV) in HCMP patients.

    Summary:

    • An unfavorable MMP-3 1171 allele variant was linked to interventricular septum hypertrophy.
    • TIMP-1 levels were significantly lower in HCMP patients compared to controls.
    • Elevated MMP-3 concentrations were observed in HCMP patients with atrial fibrillation, correlating with cardiac structural changes.

    Impact:

    • Findings confirm the role of the MMP system in hypertrophic remodeling in HCMP.
    • Identifies potential genetic markers (MMP-3 polymorphism) for predicting HCMP clinical course.
    • Highlights MMPs and TIMP-1 as potential therapeutic targets for managing HCMP progression.

    More Related Videos

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    3.3K
    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    6.6K

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    801
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    809
    Role of Matrix Metalloproteases in Degradation of ECM01:23

    Role of Matrix Metalloproteases in Degradation of ECM

    Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
    2.9K
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    745
    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    642
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    1.6K